SuperSaturated Oxygen in STEMI to Reduce Infarct Size: A New FDA-Approved Therapy

Monday, May 20, 2019: 6:45 AM-7:45 AM
Castellana Ballroom 2 (The Cosmopolitan of Las Vegas)

Sponsored By:

We invite you to dine and learn about a newly approved therapy for anterior STEMI patients to further reduce infarct size. SSO2 Therapy delivers hyperbaric levels of oxygen to the LCMA following successful PCI. Join Gregg Stone, M.D., FSCAI and this esteemed panel to delve into the background, application, and data on SSO2 Therapy.
Moderator:
Gregg W. Stone, M.D., FSCAI
6:45 AM
Welcome and Introduction
Gregg W. Stone, M.D., FSCAI, Cardiovascular Research Foundation
6:50 AM
The importance of myocardial recovery and infarct size
Richard Schatz, M.D., Scripps Clinic-Torrey Pines
7:00 AM
SuperSaturated Oxygen Therapy: Background and Pre-Clinical Studies
Shukri W David, M.D., FSCAI, Ascension Providence Hospital
7:10 AM
SuperSaturated Oxygen Therapy: Clinical Outcomes and Infarct Size Reduction
Gregg W. Stone, M.D., FSCAI, Cardiovascular Research Foundation
7:20 AM
Practical Application: Case Presentation
Amir Lotfi, M.D., FSCAI, Baystate Medical Center
7:30 AM
Audience Discussion With Q & A
7:40 AM
Closing Remarks by Gregg W. Stone, M.D., FSCAI
See more of: Satellite Sessions
<< Previous Satellite | Next Satellite >>